← Back to Screener
GlucoTrack, Inc. Common Stock (GCTK)
Price$0.74
Favorite Metrics
Price vs S&P 500 (26W)-95.27%
Price vs S&P 500 (4W)-38.63%
Market Capitalization$1.45M
All Metrics
Book Value / Share (Quarterly)$3.11
P/TBV (Annual)3.19x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-16.84
Price vs S&P 500 (YTD)-83.37%
Net Profit Margin (TTM)-3871.60%
EPS (TTM)$-58.57
10-Day Avg Trading Volume3.13M
EPS Excl Extra (TTM)$-58.57
EPS (Annual)$-1.71
ROI (Annual)-209.17%
Net Profit Margin (5Y Avg)-4767.59%
Cash / Share (Quarterly)$8.11
ROA (Last FY)-144.69%
EBITD / Share (TTM)$-25.88
ROE (5Y Avg)-117.85%
Operating Margin (TTM)-3937.33%
Cash Flow / Share (Annual)$-16.84
P/B Ratio0.51x
P/B Ratio (Quarterly)1.25x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-333.88x
ROA (TTM)-215.72%
EPS Incl Extra (Annual)$-1.71
Current Ratio (Annual)1.61x
Quick Ratio (Quarterly)1.61x
3-Month Avg Trading Volume0.99M
52-Week Price Return-92.69%
Revenue / Employee (TTM)$-0
Tangible BV / Share (Quarterly)$0.27
P/S Ratio (Annual)6.94x
Asset Turnover (Annual)0.19x
52-Week High$15.90
Operating Margin (5Y Avg)-4535.96%
EPS Excl Extra (Annual)$-1.71
CapEx CAGR (5Y)12.62%
26-Week Price Return-91.29%
Quick Ratio (Annual)1.61x
13-Week Price Return-80.48%
Total Debt / Equity (Annual)1.21x
Current Ratio (Quarterly)1.61x
Enterprise Value$-2.52
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-1684.00%
Cash / Share (Annual)$8.11
3-Month Return Std Dev143.93%
Net Income / Employee (TTM)$-2
ROE (Last FY)-221.99%
Net Interest Coverage (Annual)-2.02x
EPS Basic Excl Extra (Annual)$-1.71
Receivables Turnover (TTM)-0.03x
Total Debt / Equity (Quarterly)1.21x
EPS Incl Extra (TTM)$-58.57
Receivables Turnover (Annual)0.00x
ROI (TTM)-289.17%
P/S Ratio (TTM)19.33x
Pretax Margin (5Y Avg)-4767.59%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.08
Price vs S&P 500 (52W)-122.52%
Year-to-Date Return-80.73%
5-Day Price Return14.70%
EPS Normalized (Annual)$-1.71
ROA (5Y Avg)-147.55%
Net Profit Margin (Annual)-1684.00%
Month-to-Date Return14.74%
Cash Flow / Share (TTM)$-0.31
EBITD / Share (Annual)$-1.71
Operating Margin (Annual)-1678.93%
LT Debt / Equity (Annual)0.08x
ROI (5Y Avg)-107.43%
LT Debt / Equity (Quarterly)0.08x
EPS Basic Excl Extra (TTM)$-58.57
P/TBV (Quarterly)0.71x
P/B Ratio (Annual)1.25x
Pretax Margin (TTM)-3871.60%
Book Value / Share (Annual)$3.11
Price vs S&P 500 (13W)-81.16%
Beta0.54x
Revenue / Share (TTM)$-0.00
ROE (TTM)-393.33%
52-Week Low$0.62
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
GCTKGlucoTrack, Inc. Common Stock | 19.33x | — | — | -3937.33% | $0.74 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
GlucoTrack Inc is a medical device company developing long-term implantable continuous glucose monitoring (CBGM) systems. The company's GlucoTrack model provides real-time blood glucose measurement for insulin-dependent individuals and those at risk of hypoglycemia in the U.S., offering a more accurate and convenient approach to daily diabetes management.